68Ga/161Tb-CP2 as a Paired Radiopharmaceutical Targeting KDM4A and the Preliminary Verification in NCI-H2228 Xenografts Model
Saved in:
Main Authors: | Yu Zhang, Qingqing Li, Fengling Shan, Ao Li, Danni Li, Xiaoxu Dong, Zhiyi Lin, Xiao Li, Shuai Xue, Wenxin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2025-06-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.5c03248 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic virus VG161 offers new hope for refractory liver cancer
by: Jinqiu Li, et al.
Published: (2025-07-01) -
Zebrafish xenografts in breast cancer research
by: Xingyan Rong, et al.
Published: (2025-07-01) -
Radiopharmaceuticals: progress and clinical perspectives /
Published: (1986) -
Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01) -
Regulation of Radiopharmaceutical Products
by: V. V. Kosenko, et al.
Published: (2022-12-01)